BioSpace News Archive

The coalition brings together Fortune 100 enterprises, industry associations, public agencies, and entrepreneurs to collaboratively solve global health challenges

Gerber’s PPE Task Force has brought more than 600 companies and leading associations together to fight COVID-19.

The U.S. Food and Drug Administration has issued a warning letter to a company that markets fraudulent and dangerous chlorine dioxide products known as “Miracle Mineral Solution” for prevention and treatment of “Novel Coronavirus Disease 2019" (COVID-19).

Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, president and chief executive officer, will present a corporate overview at the 19th Annual Needham Virtual Healthcare Conference on Wednesday, April 15th at 9:20 a.m. EDT.

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported preliminary revenue results for the three months ended March 31, 2020

Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with management on Monday, April 13, 2020, at 4:30 p.m. ET to discuss the company’s preliminary first quarter 2020 financial results and provide an operational update on matters including COVID-19,

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced preliminary first quarter 2020 revenue and provided a business update, including the actions it is taking in response to COVID-19.

Engineered and designed by CRB, Andover Clinical Manufacturing Facility focuses on integration and flexibility to speed patient therapies

The American Diabetes Association (ADA) is pleased to announce that Robert A. Gabbay, MD, PhD has been named Chief Scientific & Medical Officer (CSMO).

Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), announces that at the Corporation’s Annual General Meeting (AGM) held today the Corporation’s shareholders voted to support all of the resolutions that came before the meeting.